Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
5.64
0.06 (1.08%)
At close: Sep 26, 2025, 10:59 AM
1.08% (1D)
| Bid | 5.64 |
| Market Cap | 214.53M |
| Revenue (ttm) | 79.48M |
| Net Income (ttm) | -73.35M |
| EPS (ttm) | -2.03 |
| PE Ratio (ttm) | -2.78 |
| Forward PE | -1.26 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.67 |
| Volume | 37,080 |
| Avg. Volume (20D) | 268,666 |
| Open | 5.61 |
| Previous Close | 5.58 |
| Day's Range | 5.60 - 5.73 |
| 52-Week Range | 4.93 - 21.79 |
| Beta | -0.13 |
| Ex-Dividend Date | n/a |
About TRDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEntrada Therapeutics Inc. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
